0001062993-24-008309.txt : 20240411 0001062993-24-008309.hdr.sgml : 20240411 20240411173453 ACCESSION NUMBER: 0001062993-24-008309 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240409 FILED AS OF DATE: 20240411 DATE AS OF CHANGE: 20240411 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Grant Richard N. Jr. CENTRAL INDEX KEY: 0001821315 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36117 FILM NUMBER: 24839498 MAIL ADDRESS: STREET 1: C/O INTEST CORP STREET 2: 804 EAST GATE DR, SUITE 200 CITY: MT. LAUREL STATE: NJ ZIP: 08054 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTEST CORP CENTRAL INDEX KEY: 0001036262 STANDARD INDUSTRIAL CLASSIFICATION: INSTRUMENTS FOR MEAS & TESTING OF ELECTRICITY & ELEC SIGNALS [3825] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 222370659 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 804 EAST GATE DR., SUITE 200 CITY: MT. LAUREL STATE: NJ ZIP: 08054 BUSINESS PHONE: 856-505-8800 MAIL ADDRESS: STREET 1: 804 EAST GATE DR., SUITE 200 CITY: MT. LAUREL STATE: NJ ZIP: 08054 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0508 4 2024-04-09 0001036262 INTEST CORP INTT 0001821315 Grant Richard N. Jr. C/O INTEST CORP 804 EAST GATE DR, SUITE 200 MT. LAUREL NJ 08054 1 1 0 0 President & CEO 1 Common Stock 2024-04-09 4 S 0 20000 12.8 D 215217 D Common Stock 2024-04-10 4 S 0 22000 12.03 D 193217 D Common Stock 2024-04-11 4 S 0 21500 12.03 D 171717 D Employee Stock Option (right to buy) 11.33 2034-03-05 Common Stock 30536 30536 D Employee Stock Option (right to buy) 16.06 2033-03-07 Common Stock 16988 16988 D Employee Stock Option (right to buy) 9.76 2032-03-08 Common Stock 25692 25692 D Employee Stock Option (right to buy) 10.62 2031-03-09 Common Stock 112000 112000 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2023. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.46 to $13.23, inclusive. Mr. Grant undertakes to provide inTEST Corporation, any security holder of inTEST Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.83 to $12.56, inclusive. Mr. Grant undertakes to provide inTEST Corporation, any security holder of inTEST Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.91 to $12.20, inclusive. Mr. Grant undertakes to provide inTEST Corporation, any security holder of inTEST Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. This option vests in four equal annual installments commencing on March 6, 2025. This option vests in four equal annual installments commencing on March 8, 2024. This option vests in four equal annual installments commencing on March 9, 2023. This option vests in four equal annual installments commencing on March 10, 2022. /s/ Richard N. Grant, Jr. 2024-04-11